Report : North America Adenosine Triphosphate (ATP) Swab Test Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Free ATP Test and Microbial ATP Test) and Application (Pharmaceutical & Biotechnology Company, Food & Beverage, Hospitals & Diagnostics Laboratories, and Academic & Research Institutions)
The microbial ATP test segment by type is estimated to lead the market growth during the forecast period.
According to a new market research study of “North America Adenosine Triphosphate (ATP) Swab Test Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type, Application and Country.” The North America Adenosine Triphosphate (ATP) swab test market is expected to reach US$ 132.91 million by 2027 from US$ 69.83 million in 2019. The market is estimated to grow with a CAGR of 8.4% from 2020 to 2027. The report highlights trends prevailing in the North America Adenosine Triphosphate (ATP) swab test market and the factors driving market along with those that act as hindrances.
The Adenosine Triphosphate (ATP) Swab Test market, based on the type was segmented into free ATP test, microbial ATP test. in 2019, microbial ATP test segment held the largest share of the market, and the same segment is expected to grow at the fastest rate during the coming year. The ATP Swab test is a fast calculation by identification of adenosine triphosphate or ATP of aggressively developing microorganisms. ATP is a molecule in and near living cells that explicitly tests the organisms' biological production and well-being. Healthcare-associated infectious (HAI) are caused while receiving treatments or therapies in healthcare facilities. These infections are related to surgical procedures and medical instruments used during operations. The rising prevalence of HAIs is one of the prominent factors driving the demand for ATP swab tests. For instance, according to a study published by the Centers for Disease Control and Prevention (CDC) in 2019, an estimated 1 in 31 hospital patients has some healthcare-associated infection (HAI) across the globe. Such a substantial prevalence of healthcare-associated disorders propels the adoption of the ATP swab test. Also, the utilization of adenosine triphosphate is a major indicator of cleanliness and sterilization in food & beverages. Hence, the rising incidence of foodborne diseases and food contamination is prominently expected to drive the growth of the North America Adenosine Triphosphate (ATP) swab test market during the forecast period.
The growth of the market is attributed to some key driving factors such as rising prevalence of healthcare associated infections (HAI) and increasing emphasis on food safety. However, limitations of ATP swab tests are a major factor hindering the market growth.
Hygiena, LLC, Charm Sciences, 3M, Neogen Corporation, Ecolab, MERCK KGaA, Ruhof Healthcare Corporation, LuminUltra Technologies Ltd. are among the leading companies operating in the North America Adenosine Triphosphate (ATP) swab test market.
The report segments in North America Adenosine Triphosphate (ATP) Swab Test Market as follows:
By Type
- Free ATP Test
- Microbial ATP Test
By Application
- Pharmaceutical and Biotechnology Company
- Food and Beverage
- Hospitals and Diagnostics Laboratories
- Academic and Research Institutions
By Country
- US
- Canada
- Mexico
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com